Skip to main content
  • News
  • Contact Us
  • |
  • International
  • United States
  • Canada
Leadiant Biosciences
Menu
  • About Leadiant Biosciences
    • Management Team
  • Research and Development
  • Products
  • Diseases
    • CTX
    • Hodgkin Disease
Close Search
All Posts By

daniela.perri

Recent Posts

  • EMA grants Marketing Authorization for Chenodeoxycholic Acid Leadiant

Archives

  • April 2017
Leadiant Biosciences
Leadiant Biosciences Ltd.
21 Holborn Viaduct
London
EC1A 2DY
UK
©2022 Leadiant Biosciences Ltd. / London, UK
GL-NP-2200012
Date of Production: July, 2022
  • About Leadiant Biosciences
    • Management Team
  • Research and Development
  • Products
  • Diseases
    • CTX
    • Hodgkin Disease
  • Contact Us
  • Privacy Policy
  • Disclosure
  • Sitemap
  • Modern Slavery Act Statement (PDF)
  • Leadiant Biosciences, Inc. (U.S. and Canada)
Close Menu
  • About Leadiant Biosciences
    • Management Team
  • Research and Development
  • Products
  • Diseases
    • CTX
    • Hodgkin Disease
  • News
  • Contact Us
  • |
  • International
  • United States
  • Canada
  • About Leadiant Biosciences
    • Management Team
    • Back
  • Research and Development
  • Products
  • Diseases
    • CTX
    • Hodgkin Disease
    • Back
  • Contact Us
  • United States
  • Canada

You are now leaving the Leadiant Biosciences Ltd. website and entering the Leadiant Biosciences Inc. Canada website. The information is intended for Canadian audiences only.

Continue Cancel

You are now leaving the Leadiant Biosciences Ltd. website and entering the Leadiant Biosciences Inc. U.S. website. The information is intended only for residents of the United States.

Continue Cancel

You are now leaving the Leadiant Biosciences Ltd. website and entering the Leadiant Biosciences S.p.A. (Corporate) website.

Continue Cancel